Facebook to buy Little Eye Labs in first India deal
REUTERS - Facebook Inc(FB.O) is buying India-based Little Eye Labs, a startup that builds performance analysis and monitoring tools for mobile Android apps, to help boost its technology as it focuses on growing revenue from its mobile business.
The terms of the deal were not disclosed, but media reports suggest the price was less than $15 million. A Facebook spokesman said the company would not comment on the terms of the deal.
"The Little Eye Labs technology will help us to continue improving our Android codebase to make more efficient, higher-performing apps," Subbu Subramanian, Facebook's engineering manager said.
The deal, the social networking giant's first in India, could likely boost interest in the country's startups.
Bangalore-based Little Eye Labs' team will move to Facebook's headquarters in Menlo Park, California, the company said in a statement on its website. (link.reuters.com/qud85v)
"We released our official version of Little Eye for Android in early April of this year, and since then we have had many Android developers and testers using Little Eye Labs to measure, analyze, and optimize their app's performance," the company said.
The one-year old company is backed by GSF and VenturEast Tenet Fund.
(Reporting by Sruthi Ramakrishnan in Bangalore; Editing by Supriya Kurane)
- Tweet this
- Share this
- Digg this
- Ukraine seeks to join NATO; defiant Putin compares Kiev to Nazis
- Comedian Joan Rivers remains in serious condition at N.Y. hospital
- UPDATE 4-Iceland says eruption over, lifts all airspace restrictions
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- REVIEW-Bogdanovich's "She's Funny That Way" milks laughs in Venice
India's economy grew by a faster-than-expected 5.7 percent in the three months through June, its fastest pace in two-and-a- half years, helped by a rebound in manufacturing and mining sectors, government data showed on Friday. Full Article
Exclusive: Reliance plans $13 billion projects including new refinery. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article